featured
Lentiviral Hemopoietic Stem/Progenitor Cell Gene Therapy for Treatment of Wiskott-Aldrich Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lentiviral Haemopoietic Stem/Progenitor Cell Gene Therapy for Treatment of Wiskott-Aldrich Syndrome: Interim Results of a Non-Randomised, Open-Label, Phase 1/2 Clinical Study
Lancet Haematol 2019 Apr 10;[EPub Ahead of Print], F Ferrua, MP Cicalese, S Galimberti, S Giannelli, F Dionisio, F Barzaghi, M Migliavacca, ME Bernardo, V Calbi, AA Assanelli, M Facchini, C Fossati, E Albertazzi, S Scaramuzza, I Brigida, S Scala, L Basso-Ricci, R Pajno, M Casiraghi, D Canarutto, FA Salerio, MH Albert, A Bartoli, HM Wolf, R Fiori, P Silvani, S Gattillo, A Villa, L Biasco, C Dott, EJ Culme-Seymour, K van Rossem, G Atkinson, MG Valsecchi, MG Roncarolo, F Ciceri, L Naldini, A AiutiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.